These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6634675)

  • 1. [Immunologic aspects of myocardial damage during long-term administration of antitubercular preparations].
    Iakovleva TA; Red'kin IuV; Dolgikh VT; Sokolova TF
    Probl Tuberk; 1983 Jul; (7):31-4. PubMed ID: 6634675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaco-toxocologic study of the anti-tuberculosis preparation prothionimide].
    Il'in AM
    Farmakol Toksikol; 1975; 38(4):471-2. PubMed ID: 1213138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes.
    Dolgushin MV
    Bull Exp Biol Med; 2020 Feb; 168(4):470-473. PubMed ID: 32146623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M; de Montaigne E
    Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the nature of the hepatotoxic action of isoniazid, rifamicin, ethambutol and their combinations against a background of prolonged alcohol administration].
    Ortenberg EA; Zhikhareva AI
    Probl Tuberk; 1980 Feb; (2):59-62. PubMed ID: 7375466
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of the antioxidant ionol to prevent damage to the heart from prolonged administration of antitubercular preparations].
    Iakovleva TA; Dolgikh VT; Poluéktov LV
    Biull Eksp Biol Med; 1983 Oct; 96(10):59-62. PubMed ID: 6626733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood-level of prothionamide following oral administratton of prothionamide alone or in combination with isoniazid and/or with diamino-diphenylsulfon].
    Franz H; Urbanczik R; Stoll K; Müller U
    Prax Pneumol; 1974 Nov; 28(11):605-12. PubMed ID: 4453524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepato-biliary effect of the rifomycin-prothionamid combination. I. Histological study on the rat].
    Hugues FC; Marche C; Marche J
    Therapie; 1970; 25(1):131-6. PubMed ID: 5436795
    [No Abstract]   [Full Text] [Related]  

  • 9. [Haemoglobin levels during prolonged treatment with isoprodian, a combination of isoniazid, prothionamide and diaphenylsulphone (author's transl)].
    Hoose C
    Prax Pneumol; 1976 Jul; 30(7):435-8. PubMed ID: 967821
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepato-biliary effect of the rifomycin-isoniazid combination. II. Histological study on tuberculized mice].
    Balea T; Marche C; Marche J
    Therapie; 1970; 25(1):125-30. PubMed ID: 5436794
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoprodian in ambulatory therapy of pulmonary tuberculosis].
    Opl G; Novak M
    Prax Klin Pneumol; 1980 Dec; 34(12):715-8. PubMed ID: 7465531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute toxic action of combinations of antibiotics with isoniazid].
    Ziia AV; Sokolova GB; Lebedeva MN
    Antibiotiki; 1982; 27(7):535-9. PubMed ID: 7137978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin drug interactions.
    Holdiness MR
    Arch Intern Med; 1987 Oct; 147(10):1856. PubMed ID: 3662720
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental study of therapeutic effect of various antibacterial drug combinations].
    Kozulitsyna TI; Uvarova OA; Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1980 Jul; (7):49-53. PubMed ID: 7413637
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic activity of antileprosy drugs and their derivatives.
    Peters JH; Gordon GR; Murray JF; Simmon VF
    Int J Lepr Other Mycobact Dis; 1983 Mar; 51(1):45-53. PubMed ID: 6683259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ON THE PROBLEM OF THE IDENTIFICATION OF SOME ANTITUBERCULAR PREPARATIONS].
    SHILOV IuM; CHICHIRO VE
    Aptechn Delo; 1963; 12():65-8. PubMed ID: 14055392
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptability of thioamides. II. Prothionamide.
    Gupta DK
    J Postgrad Med; 1977 Oct; 23(4):181-5. PubMed ID: 615265
    [No Abstract]   [Full Text] [Related]  

  • 20. [New aspects of chemotherapy of tuberculosis].
    Khomenko AG
    Probl Tuberk; 1980 Jul; (7):14-9. PubMed ID: 7413630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.